Latest Breaking News On - Amphastar nanjing pharmaceuticals - Page 1 : comparemela.com

Amphastar Pharmaceuticals, Inc : Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ("FDA") has granted approval for the Company's

United statesJack zhangTeva respiratoryExchange commissionCo ltdCompany informationMost of the companyCompany abbreviated new drug applicationAmphastar nanjing pharmaceuticalsDrug administrationAmphastar pharmaceuticals incAmphastar pharmaceuticalsAbbreviated new drug applicationAlbuterol sulfate inhalation aerosolInhalation aerosolDrug master files

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

United statesJack zhangAmphastar pharmaceuticals incAmphastar nanjing pharmaceuticalsMost of the companyDrug administrationAmphastar pharmaceuticals inc bill peterschief financialCo ltdCompany abbreviated new drug applicationNews networkExchange commissionTeva respiratoryCompany informationAmphastar pharmaceuticalsAbbreviated new drug applicationAlbuterol sulfate inhalation aerosol

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ("FDA") has granted approval for the Company's Abbreviated New Drug Application ("ANDA") for Albuterol Sulfate Inhalation Aerosol, previously.

United statesJack zhangAmphastar pharmaceuticals incCompany abbreviated new drug applicationAmphastar nanjing pharmaceuticalsCompany informationExchange commissionDrug administrationCo ltdMost of the companyTeva respiratoryAmphastar pharmaceuticalsAbbreviated new drug applicationAlbuterol sulfate inhalation aerosolInhalation aerosolDrug master files

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Jack zhangCompany informationExchange commissionTransition services agreementMost of the companyAmphastar nanjing pharmaceuticalsCo ltdEli lilly companyDrug administrationAmphastar pharmaceuticals incReports net revenuesThree months ended marchAmphastar pharmaceuticalsChief executive officerEli lillyProduct revenues

Amphastar Pharmaceuticals Reports Financial Results for the Three Months

Amphastar Pharmaceuticals Reports Financial Results for the Three Months
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Jack zhangDrug administrationEli lilly companyCo ltdNews networkTransition services agreementAmphastar pharmaceuticals incCompany informationAmphastar nanjing pharmaceuticalsPharmaceuticals reports financial resultsThree monthsNet revenuesThree months ended marchAmphastar pharmaceuticalsQuarter highlightsChief executive officer